WithdrawnPhase 2

Failed Endometrial Ablation Treatment With Implantable Progesterone (FEAT) Study

Stopped: Difficulty in Recruitment

Canada0Started 2022-07-01

Plain-language summary

The objective of this study is to assess the efficacy of an implantable etonogestrel device in reducing hysterectomy rate in patients with a failed endometrial ablation.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Previous endometrial ablation * Pelvic pain and/or vaginal bleeding seeking treatment Exclusion Criteria: * Previous or current VTE * Liver tumour, benign or malignant, or active liver disease * Undiagnosed abnormal genital bleeding * Known or suspected breast cancer * Uncontrolled hypertension * Allergy to component of etonogestrel implant * Lack of patient consent

What they're measuring

Hysterectomy

Timeframe: Occurrence of hysterectomy will be documented any time during the 3 year follow up period

Trial details

NCT IDNCT05227456

SponsorSaskatchewan Health Authority - Regina Area

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-04-30

View on ClinicalTrials.gov More Abnormal Uterine Bleeding trials